Arachidonate 5-Lipoxygenase (ALOX5) (Middle Region) Peptide
Our Local Distributor
北京 101111
Quick Overview for Arachidonate 5-Lipoxygenase (ALOX5) (Middle Region) Peptide (ABIN8094892)
抗原
宿主
资源
应用范围
-
-
蛋白结构域
- Middle Region
-
原理
- ALOX5 Peptide - middle region
-
序列
- RRKELETRQK QYRWMEWNPG FPLSIDAKCH KDLPRDIQFD SEKGVDFVLN
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
This is a synthetic peptide designed for use in combination with anti- ALOX5 Antibody (ARP83886_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
缓冲液
- Lyophilized powder
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ALOX5 (Arachidonate 5-Lipoxygenase (ALOX5))
-
背景
-
Background Information: This gene encodes a member of the lipoxygenase gene family and plays a dual role in the synthesis of leukotrienes from arachidonic acid. The encoded protein, which is expressed specifically in bone marrow-derived cells, catalyzes the conversion of arachidonic acid to 5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid, and further to the allylic epoxide 5(S)-trans-7,9-trans-11,14-cis-eicosatetrenoic acid (leukotriene A4). Leukotrienes are important mediators of a number of inflammatory and allergic conditions. Mutations in the promoter region of this gene lead to a diminished response to antileukotriene drugs used in the treatment of asthma and may also be associated with atherosclerosis and several cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative Symbols: 5-LO, 5LPG, LOG5, 5-LOX
-
分子量
- 53 kDa
-
基因ID
- 240
-
NCBI登录号
- NP_000689
-
UniProt
- P09917
抗原
-